Focus: Variational AI is a Vancouver-based biotechnology company founded in 2019 specializing in small molecule drug discovery using computational approaches. The company operates at pre-commercial stage with a focused R&D footprint.
Profile data last refreshed 9h ago · AI intelligence enriched 2w ago
Best suited for early-career scientists or computational specialists willing to trade stability for upside in an unfunded or recently-funded discovery-stage venture.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Variational AI
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Variational AI's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo